Nothing Special   »   [go: up one dir, main page]

WO2001029072A3 - Proteines du cycle cellulaire p15paf associees a l'antigene pcna, compositions et methodes d'utilisation - Google Patents

Proteines du cycle cellulaire p15paf associees a l'antigene pcna, compositions et methodes d'utilisation Download PDF

Info

Publication number
WO2001029072A3
WO2001029072A3 PCT/US2000/041296 US0041296W WO0129072A3 WO 2001029072 A3 WO2001029072 A3 WO 2001029072A3 US 0041296 W US0041296 W US 0041296W WO 0129072 A3 WO0129072 A3 WO 0129072A3
Authority
WO
WIPO (PCT)
Prior art keywords
present
methods
cell cycle
compositions
polypeptides
Prior art date
Application number
PCT/US2000/041296
Other languages
English (en)
Other versions
WO2001029072A2 (fr
WO2001029072A9 (fr
Inventor
Ying Luo
Peiwen Yu
Betty Huang
Original Assignee
Rigel Pharmaceuticals Inc
Ying Luo
Peiwen Yu
Betty Huang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc, Ying Luo, Peiwen Yu, Betty Huang filed Critical Rigel Pharmaceuticals Inc
Priority to EP00984557A priority Critical patent/EP1224470A2/fr
Priority to AU21158/01A priority patent/AU2115801A/en
Priority to JP2001531870A priority patent/JP2003513231A/ja
Priority to CA002387731A priority patent/CA2387731A1/fr
Publication of WO2001029072A2 publication Critical patent/WO2001029072A2/fr
Publication of WO2001029072A3 publication Critical patent/WO2001029072A3/fr
Publication of WO2001029072A9 publication Critical patent/WO2001029072A9/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La présente invention concerne des polypeptides, des acides nucléiques et des molécules apparentées qui ont une incidence sur le cycle cellulaire ou qui sont en rapport avec ledit cycle. L'invention concerne également des vecteurs et des cellules hôtes renfermant lesdites séquences d'acides nucléiques, des molécules polypeptidiques chimères comprenant les polypeptides selon l'invention fusionnées à des séquences polypeptidiques hétérologues, des anticorps qui se lient aux polypeptides de l'invention, ainsi que des méthodes d'obtention desdits polypeptides. Cette invention concerne également des méthodes d'identification de compositions qui induisent une bioactivité du cycle cellulaire ainsi que l'utilisation de ces méthodes pour le diagnostic et le traitement de la maladie.
PCT/US2000/041296 1999-10-18 2000-10-18 Proteines du cycle cellulaire p15paf associees a l'antigene pcna, compositions et methodes d'utilisation WO2001029072A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP00984557A EP1224470A2 (fr) 1999-10-18 2000-10-18 Proteines du cycle cellulaire p15paf associees a l'antigene pcna, compositions et methodes d'utilisation
AU21158/01A AU2115801A (en) 1999-10-18 2000-10-18 P15paf cell cycle proteins associated with pcna, compositions and methods of use
JP2001531870A JP2003513231A (ja) 1999-10-18 2000-10-18 Ｐｃｎａ関連ｐ１５ｐａｆ細胞周期タンパク質、組成物および使用法
CA002387731A CA2387731A1 (fr) 1999-10-18 2000-10-18 Proteines du cycle cellulaire p15paf associees a l'antigene pcna, compositions et methodes d'utilisation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42009299A 1999-10-18 1999-10-18
US09/420,092 1999-10-18

Publications (3)

Publication Number Publication Date
WO2001029072A2 WO2001029072A2 (fr) 2001-04-26
WO2001029072A3 true WO2001029072A3 (fr) 2002-01-17
WO2001029072A9 WO2001029072A9 (fr) 2002-08-01

Family

ID=23665049

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/041296 WO2001029072A2 (fr) 1999-10-18 2000-10-18 Proteines du cycle cellulaire p15paf associees a l'antigene pcna, compositions et methodes d'utilisation

Country Status (5)

Country Link
EP (1) EP1224470A2 (fr)
JP (1) JP2003513231A (fr)
AU (1) AU2115801A (fr)
CA (1) CA2387731A1 (fr)
WO (1) WO2001029072A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0410498D0 (en) * 2004-05-11 2004-06-16 Cyclacel Ltd Crystal

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000055350A1 (fr) * 1999-03-12 2000-09-21 Human Genome Sciences, Inc. Sequences et polypeptides geniques associes au cancer chez l'homme

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000055350A1 (fr) * 1999-03-12 2000-09-21 Human Genome Sciences, Inc. Sequences et polypeptides geniques associes au cancer chez l'homme

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 8 February 2001 (2001-02-08), XP002171327 *
DATABASE SWISS-PROT 15 July 1998 (1998-07-15), "Hypothetical protein KIAA0101", XP002171326 *
NAGASE, T. ET AL.: "Prediction of the coding sequences of unidentified human genes. III. The coding sequences of 40 new genes (KIAA0081-KIAA0120) deduced by analysis of cDNA clones from human cell line KG-1", DNA RESEARCH, vol. 2, no. 1, 28 February 1995 (1995-02-28), pages 37 - 43, XP001011422 *
YU, PEIWEN ET AL: "p15PAF, a novel PCNA associated factor with increased expression in tumor tissues", ONCOGENE, 20(4), 484-489, 25 January 2001 (2001-01-25), XP001011484 *

Also Published As

Publication number Publication date
JP2003513231A (ja) 2003-04-08
AU2115801A (en) 2001-04-30
EP1224470A2 (fr) 2002-07-24
WO2001029072A2 (fr) 2001-04-26
WO2001029072A9 (fr) 2002-08-01
CA2387731A1 (fr) 2001-04-26

Similar Documents

Publication Publication Date Title
EP1690873A3 (fr) Composition et procédés de diagnostic de tumeurs
WO2001042437A3 (fr) Proteines histone deacetylase-8, acides nucleiques et technique d'utilisation
WO2001064913A3 (fr) Proteines de cycle cellulaire associees au rad9, compositions et procedes d'utilisation
WO2001087978A3 (fr) La 38594, nouveau transporteur humain et ses utilisations
WO2000039149A3 (fr) Proteines secretees et leurs utilisations
WO2001030987A3 (fr) Tankyrase h, compositions intervenant dans le cycle cellulaire et procedes d'utilisation
WO2001021654A3 (fr) Nouvelles proteines du cycle cellulaire associees a la kinase syk, compositions et techniques d'utilisation
WO2001036476A3 (fr) Nouvelles proteines de cycle cellulaire associees a un inhibiteur de proteines de l'apoptose, compositions et procedes d'utilisation
WO2000043419A3 (fr) Proteine de voies d'exocytose et leurs procedes d'utilisation
WO2001036474A3 (fr) Nouvelles proteines de cycle cellulaire associees au rip3, compositions et procedes d'utilisation
WO2001029072A3 (fr) Proteines du cycle cellulaire p15paf associees a l'antigene pcna, compositions et methodes d'utilisation
WO2001029197A3 (fr) Nouvelles proteines du cycle cellulaire a kinases du centre germinatif, compositions et methodes d'utilisation
WO2001021784A3 (fr) Nouvelles proteines du cycle cellulaire associees a l'antigene pcna, compositions et procedes d'utilisation
WO1999042586A3 (fr) Proteines exocytotiques, exo 2, exo 2
WO2000018923A3 (fr) Proteine et nouvelle molecule d'acide nucleique slgp et utilisations de celles-ci
WO2003020912A3 (fr) Nouvelle proteine cark et molecules d'acides nucleiques et leurs utilisation
EP1241179A3 (fr) Protéine semblable à un cornichon et acides nucléiques le codant
WO2002034896A3 (fr) 13245, une nouvelle proteine kinase humaine de type a dystrophie myotonique et ses utilisations
WO2000007545A8 (fr) Nouvelles proteines d'apoptose
WO2001021799B1 (fr) Proteines du cycle cellulaire associees a la traf4, compositions et modalites d'utilisation
EP1666497A3 (fr) Polypeptide, acides nucléiques le codant, et leur utilisation pour le diagnostic du cancer
WO2001090146A3 (fr) Nouveaux transporteurs humains, 57256 et 58289, et utilisations correspondantes
EP2050762A3 (fr) Nouvelles polypeptides et acides nucléiques les codant
EP1251139A3 (fr) Protéine semblable à mendin humain et acides nucléiques le codant
WO2001072828A3 (fr) 26649, une nouvelle molecule activant la gtpase humaine et ses applications

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 531870

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2387731

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 21158/01

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2000984557

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000984557

Country of ref document: EP

AK Designated states

Kind code of ref document: C2

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

COP Corrected version of pamphlet

Free format text: PAGES 1/9-9/9, DRAWINGS, REPLACED BY NEW PAGES 1/6-6/6; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

WWW Wipo information: withdrawn in national office

Ref document number: 2000984557

Country of ref document: EP